利润表
IMMUNIC, INC.
IMUX
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
毛利润
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业费用
|
103.23 | 98.05 | 99.22 | 119.49 | 91.67 | 48.97 | 37.03 | 42.02 | 52.66 | 41.27 | 52.12 | 50.34 |
|
研发费用
|
81.98 | 80.05 | 83.22 | 71.26 | 61.12 | 38.64 | 22.51 | 24.83 | 39.34 | 30.05 | 39.77 | 39.48 |
|
销售、一般及行政费用
|
21.25 | 18.01 | 16.01 | 15.26 | 13.30 | 10.33 | 14.52 | 13.59 | 13.31 | 11.22 | 12.35 | 10.86 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-103.23 | -98.05 | -99.22 | -119.49 | -91.67 | -48.97 | -37.03 | -42.02 | -52.66 | -41.27 | -52.12 | -50.34 |
|
营业外收入
|
6.06 | -2.46 | 5.61 | -0.92 | -1.28 | 4.95 | 2.10 | 0.55 | 0.58 | 0.30 | 0.10 | 2.68 |
|
利息收入
|
1.04 | 3.39 | 3.08 | 1.04 | 0.07 | 0.06 | 0.11 | 0.52 | 0.65 | 0.28 | 0.06 | 0.02 |
|
利息支出
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
其他营业外收入/支出
|
5.02 | -1.05 | 2.54 | -1.96 | -1.35 | 4.90 | 1.99 | 0.03 | -0.07 | 0.01 | 0.04 | 0.06 |
|
税前利润
|
- | - | - | - | - | - | - | -41.48 | -52.08 | -40.97 | -52.02 | -47.67 |
|
所得税费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-97.17 | -100.51 | -93.61 | -120.41 | -92.95 | -44.02 | -34.93 | -41.48 | -52.08 | -40.97 | -52.02 | -47.67 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-103.06 | -97.92 | -99.11 | -119.41 | -91.58 | -48.93 | -36.98 | -41.30 | -51.66 | -39.46 | -50.79 | -49.26 |
|
基本每股收益
|
-0.62 | -1.00 | -2.11 | -3.78 | -3.93 | - | - | - | - | - | - | - |
|
稀释每股收益
|
-0.62 | -1.00 | -2.11 | -3.78 | -3.93 | - | - | - | - | - | - | - |
|
加权平均股数
|
155.69 | 100.17 | 44.32 | 31.82 | 23.65 | - | - | - | - | - | - | - |
|
稀释加权平均股数
|
155.69 | 100.17 | 44.32 | 31.82 | 23.65 | - | - | - | - | - | - | - |
|
综合收益
|
-98.73 | -100.06 | -92.89 | -117.12 | -89.09 | -46.76 | -35.49 | -41.48 | -52.08 | -40.97 | -52.03 | -47.67 |